BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Institute for Bioengineering of Catalonia - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ibecbarcelona.eu
X-WR-CALDESC:Events for Institute for Bioengineering of Catalonia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171218T120000
DTEND;TZID=Europe/Madrid:20171218T130000
DTSTAMP:20260424T142147
CREATED:20171123T104034Z
LAST-MODIFIED:20171127T103555Z
UID:56469-1513598400-1513602000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Jonel Trebicka
DESCRIPTION:Liver fibrosis and Portal hypertension\nProf. Jonel Trebicka\, Laboratory for Liver Fibrosis and Portal Hypertension\, Dept of Internal Medicine\, University of Bonn\nIn patients with chronic liver disease\, portal hypertension and progressive fibrosis are concomitant pathological processes interacting with each-other and leading to severe complications. The mechanics of matrix and the distinct response of different hepatic cell types contribute in the development of liver injury and cancer. Moreover\, cellular mechanics play a crucial role on the remodeling of matrix in chronic liver disease. Interruption of the liver injury either by treating the initial liver injury and addressing the perpetuating risk factors will improve both fibrosis and prevent or ameliorate portal hypertension. Currently\, after the successful cure of viral hepatitis\, lifestyle-related liver damage due to chronic alcoholism or morbid obesity will remain the main factor leading to liver fibrosis and portal hypertension. Even though\, the basic pathogenetic mechanisms of development of fibrosis and portal hypertension are similar. Especially RhoA/Rho-kinase pathway is crucially involved in the pathogenetic processes inside and outside the liver. RhoA/Rho-kinase is crucial in mechanics of cells\, and the modulation of these targets has been evaluated in different animal models. Also\, some well-established drugs\, which are used in humans for other indications (for example\, statins)\, are promising if applied early and concomitantly to standard therapy. In the future\, more cell-specific targeting and personalized strategies must be considered to avoid progression of disease and complications.
URL:https://ibecbarcelona.eu/event/ibec-seminar-jonel-trebicka/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Madrid:20171218T120000
DTEND;TZID=Europe/Madrid:20171218T130000
DTSTAMP:20260424T142147
CREATED:20171123T104034Z
LAST-MODIFIED:20171123T104034Z
UID:96138-1513598400-1513602000@ibecbarcelona.eu
SUMMARY:IBEC Seminar: Jonel Trebicka
DESCRIPTION:Liver fibrosis and Portal hypertension\nProf. Jonel Trebicka\, Laboratory for Liver Fibrosis and Portal Hypertension\, Dept of Internal Medicine\, University of Bonn\nIn patients with chronic liver disease\, portal hypertension and progressive fibrosis are concomitant pathological processes interacting with each-other and leading to severe complications. The mechanics of matrix and the distinct response of different hepatic cell types contribute in the development of liver injury and cancer. Moreover\, cellular mechanics play a crucial role on the remodeling of matrix in chronic liver disease. Interruption of the liver injury either by treating the initial liver injury and addressing the perpetuating risk factors will improve both fibrosis and prevent or ameliorate portal hypertension. Currently\, after the successful cure of viral hepatitis\, lifestyle-related liver damage due to chronic alcoholism or morbid obesity will remain the main factor leading to liver fibrosis and portal hypertension. Even though\, the basic pathogenetic mechanisms of development of fibrosis and portal hypertension are similar. Especially RhoA/Rho-kinase pathway is crucially involved in the pathogenetic processes inside and outside the liver. RhoA/Rho-kinase is crucial in mechanics of cells\, and the modulation of these targets has been evaluated in different animal models. Also\, some well-established drugs\, which are used in humans for other indications (for example\, statins)\, are promising if applied early and concomitantly to standard therapy. In the future\, more cell-specific targeting and personalized strategies must be considered to avoid progression of disease and complications.
URL:https://ibecbarcelona.eu/event/ibec-seminar-jonel-trebicka-4/
LOCATION:IBEC\, floor 11\, Tower I\, Baldiri Reixac 4-8\, 08028 Barcelona\, Spain
CATEGORIES:IBEC Seminar
END:VEVENT
END:VCALENDAR